Cargando…
Programmed death-ligand 1 signaling pathway involves in bladder cancer growth and progression
CONTEXT: Exploration of the biological property of programmed death-ligand 1 (PD-L1) signaling that may impact bladder tumor growth in humanized animals and cell culture. AIMS: The aim of this study is to evaluate how PD-L1 signaling involves bladder cancer growth and progression. SETTINGS AND DESIG...
Autores principales: | Samishina, Elena A., Blinova, Ekaterina V., Roshchin, Dmitry A., Suslova, Irina R., Blinov, Dmitry S., Zhdanov, Pavel N., Deryabina, Olga N., Kit’ko, Olesia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594057/ https://www.ncbi.nlm.nih.gov/pubmed/31360124 http://dx.doi.org/10.4103/jcar.JCar_3_19 |
Ejemplares similares
-
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
por: Blinova, Ekaterina, et al.
Publicado: (2019) -
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
por: Blinova, Ekaterina V., et al.
Publicado: (2018) -
Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma
por: Blinova, Ekaterina, et al.
Publicado: (2021) -
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
por: Blinova, Ekaterina, et al.
Publicado: (2020) -
Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy
por: Blinova, Ekaterina, et al.
Publicado: (2020)